December 2025 Quarterly Activities Report
Filed with ASX · · 10 pages · English
Summary by 6ix AI
The report indicates improvements in safety performance and production metrics, with notable increases in spodumene production and sales, alongside a rise in the average realized price for spodumene. Financially, the company reported a significant underlying EBITDA and positive cash flow from operating activities, maintaining a strong balance sheet with substantial net cash.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from IGO
- 1Q26 Quarterly Activities Report
- FY25 Financial Results
- Appendix 4E
- MM8: Acqn of Forrestania Plant & Infrastructure Binding
- June 2025 Quarterly Activities Report
Later from IGO
- December 2025 Half Year Financial Report and Appendix 4D
- March 2026 Quarterly Activities Report
- March 2026 Quarterly Presentation
- June 2026 Quarterly Activities Report
- June 2026 Quarterly Presentation
Follow IGO into a list and get an email when it puts out news.
Follow IGO